J Neurol Surg B Skull Base
DOI: 10.1055/a-2374-9868
Original Article

Olfactory Groove Meningiomas and the Association with Postoperative Weight Loss

Stephanie A. Armstrong
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Timothy F. Boerger
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Brandon Laing
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Samon Tavakoli
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Kaitlin Goetschel
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Stephanie Cheok
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Nathan Zwagerman
1   Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
› Author Affiliations

Abstract

Objective Olfactory groove meningiomas (OGM) commonly present with olfactory deficits and compression of the frontal lobes. Given the relationship to dietary behaviors, our objective was to evaluate the relationship between OGMs and postoperative weight loss.

Methods Retrospective review of primary resection of meningiomas between 2017 and 2023 at a single institution was conducted. Neurofibromatosis type 2, pregnancy, weight loss medications, or surgeries were excluded. Data collection included preoperative body mass index (preBMI) and postoperative BMI (poBMI) at 3 to 6 and 12 months. Percent BMI change (pcBMI) was calculated by (poBMI − preBMI/preBMI × 100%). IBM SPSS Statistics (Version 27) was used for descriptive statistics and stepwise multiple linear regression.

Results Ninety-eight patients met inclusion with a mean age of 57.58 years. Three groups were stratified by location: OGM (n = 15), anterior cranial fossa excluding OGM (ACF; n = 24), and other (OTH; n = 59). Olfactory dysfunction was present in 53.8% of the OGMs. OGM presented with significantly larger lesions (57.25 ± 55.98 mm3) and a higher preBMI (34.58 ± 7.41 kg/m2) than ACF and OTH. A greater pcBMI was seen in OGM at both timepoints (−7.74%, −8.73%). OGM location, tumor volume, and preBMI were found significant on univariate analysis (p < 0.05) and included in multiple linear regression. All regression models were significant (p = 0.001). Location significantly added to the prediction at 3 to 6 and 12 months as well as preBMI at 12 months. In a subanalysis of ACF and OGM, OGM location was significantly associated with negative pcBMI at 3 to 6 and 12 months.

Conclusion OGMs are associated with higher preoperative weight and greater weight loss postoperatively compared with other locations.

Previous Presentation

Poster Presentation at the North American Skull Base Society Annual Meeting February 16 to 18, 2024.




Publication History

Received: 31 May 2024

Accepted: 25 July 2024

Accepted Manuscript online:
29 July 2024

Article published online:
14 August 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Guduk M, Yener U, Sun HI, Hacihanefioglu M, Ozduman K, Pamir MN. Pterional and unifrontal approaches for the microsurgical resection of olfactory groove meningiomas: experience with 61 consecutive patients. Turk Neurosurg 2017; 27 (05) 707-715
  • 2 Bitter AD, Stavrinou LC, Ntoulias G. et al. The role of the pterional approach in the surgical treatment of olfactory groove meningiomas: a 20-year experience. J Neurol Surg B Skull Base 2013; 74 (02) 97-102
  • 3 Romani R, Lehecka M, Gaal E. et al. Lateral supraorbital approach applied to olfactory groove meningiomas: experience with 66 consecutive patients. Neurosurgery 2009; 65 (01) 39-52 , discussion 52–53
  • 4 Youngerman BE, Shtayer L, Gerges MM, Larsen AG, Tomasiewicz HC, Schwartz TH. Eyebrow supraorbital keyhole craniotomy for olfactory groove meningiomas with endoscope assistance: case series and systematic review of extent of resection, quantification of postoperative frontal lobe injury, anosmia, and recurrence. Acta Neurochir (Wien) 2021; 163 (01) 101-112
  • 5 Bamimore MA, Marenco-Hillembrand L, Ravindran K. et al. Smell outcomes in olfactory groove meningioma resection through unilateral versus bilateral transcranial approaches: a systematic review and meta-analysis. World Neurosurg 2022; 160: 22-32
  • 6 Dedeciusova M, Svoboda N, Benes V, Astl J, Netuka D. Olfaction in olfactory groove meningiomas. J Neurol Surg A Cent Eur Neurosurg 2020; 81 (04) 310-317
  • 7 Islam MA, Fagundo AB, Arcelus J. et al. Olfaction in eating disorders and abnormal eating behavior: a systematic review. Front Psychol 2015; 6: 1431
  • 8 Sergentanis TN, Tsivgoulis G, Perlepe C. et al. Obesity and risk for brain/CNS tumors, gliomas and meningiomas: a meta-analysis. PLoS One 2015; 10 (09) e0136974
  • 9 Dickinson H, Carico C, Nuño M, Nosova K, Elramsisy A, Patil CG. The effect of weight in the outcomes of meningioma patients. Surg Neurol Int 2013; 4: 45
  • 10 Constanthin PE, Gondar R, Fellrath J. et al. Neuropsychological outcomes after surgery for olfactory groove meningiomas. Cancers (Basel) 2021; 13 (11) 2520
  • 11 Boesveldt S, de Graaf K. The differential role of smell and taste for eating behavior. Perception 2017; 46 (3-4): 307-319
  • 12 Kindleysides S, Beck KL, Walsh DCI. et al. Fat sensation: fatty acid taste and olfaction sensitivity and the link with disinhibited eating behaviour. Nutrients 2017; 9 (08) 879
  • 13 Jaime-Lara RB, Brooks BE, Vizioli C. et al. A systematic review of the biological mediators of fat taste and smell. Physiol Rev 2023; 103 (01) 855-918
  • 14 Feller C, Del Campo EM, Montoure A. et al. Transorbital approach for resection of intracranial skull base lesions: outcomes and complications. J Neurol Surg B Skull Base 2022; 83 (S 01): A256
  • 15 Tavakoli S, Armstrong SA, Feller C, Hong SH, Zwagerman NT. Transpalpebral mini-orbitozygomatic approach for nonvascular skull base lesions: a single neurosurgeon's experience. Neurosurg Focus 2024; 56 (04) E11
  • 16 Shao C, Bai LP, Qi ZY, Hui GZ, Wang Z. Overweight, obesity and meningioma risk: a meta-analysis. PLoS One 2014; 9 (02) e90167
  • 17 Niedermaier T, Behrens G, Schmid D, Schlecht I, Fischer B, Leitzmann MF. Body mass index, physical activity, and risk of adult meningioma and glioma: a meta-analysis. Neurology 2015; 85 (15) 1342-1350
  • 18 Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006; 17 (08) 328-336
  • 19 Kurihara M, Tokunaga Y, Tsutsumi K. et al. Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma. J Neurosurg 1989; 71 (04) 538-544
  • 20 Omulecka A, Papierz W, Nawrocka-Kunecka A, Lewy-Trenda I. Immunohistochemical expression of progesterone and estrogen receptors in meningiomas. Folia Neuropathol 2006; 44 (02) 111-115
  • 21 Guinto G. Olfactory groove meningiomas. World Neurosurg 2015; 83 (06) 1046-1047
  • 22 Bander ED, Pandey A, Yan J. et al. Olfactory groove meningiomas: supraorbital keyhole versus orbitofrontal, frontotemporal, or bifrontal approaches. J Neurosurg 2023; 140 (06) 1568-1575